Company: Merz Pharma UK Ltd. Legal category: Prescription. GMS Pending. Sport Permitted. Active ingredient: Clozapine 25mg, 100mg. Description: Round flat yellow bevel edged tablets marked with strength over a pressure sensitive breakline on one face. The scoreline is only to facilitate breaking for ease of swallowing and not to divide into equal doses. Presentation: 25mg-84, [...]
Company: TEVA Pharmaceuticals Ireland. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Gliclazide 30mg. Description: White, oval, biconvex modified-release tablets. Presentation: 60, €6.57. Indications: Non insulin-dependent diabetes (type 2) in adults when dietary measures, physical exercise and weight loss alone are not sufficient to control blood glucose. Pharmacology: Gliclazide is a hypoglycaemic sulphonylurea oral antidiabetic [...]
Company: GlaxoSmithKline (Ireland) Ltd. Legal category: Prescription. Sport permitted. Active ingredient: Hepatitis B surface antigen 20mcg adjuvanted by AS04C and adsorbed on aluminium phosphate. Description: Turbid white suspension for injection in a pre-filled syringe. Presentation: 1, price available on request. Indications: Active immunisation against hepatitis B virus infection (HBV) caused by all known subtypes for [...]
Company: Helsinn Birex Therapeutics Ltd. Legal category: Prescription. GMS pending. Sport permitted. Active ingredient: Finasteride 5mg. Description: Blue, 7mm, round biconvex, film-coated tablets marked F5 on one side. Presentation: 28, €17.00. Indications: Treatment and control of benign prostatic hyperplasia (BPH) and prevention of urologic events to reduce the risk of acute urinary retention, reduce the [...]
Company: Recordati Ireland. Legal category: Precription. GMS. Sport permitted. Active ingredients: Enalapril maleate/lercanidipine hydochoride 10mg/10mg, 20mg/10mg. Description: Respectively white and yellow biconvex, round film-coated tablets. Presentation: 10mg/10mg-28, €16.08; 20mg/10mg-28, €18.30. Indications: Treatment of essential hypertension in patients whose blood pressure is not adequately controlled by lercanidipine 10mg alone. Not for initial treatment of hypertension. Pharmacology: [...]
Company: Clonmel Healthcare Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Venlafaxine hydrochloride equivalent to 37.5mg, 75mg, 150mg. Description: Respectively, size 3 with an orange cap, size 1 with a yellow cap and size 0 with a buff cap prolonged-release transparent capsules containing white to off white granules. Presentation: 37.5mg-28, €12.20; 75mg-28, €17.87; 150mg-28, [...]
Company: Gerard Laboratories. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Venlafaxine hydrochloride equivalent to 75mg, 150mg. Description: Respectively, flesh or scarlet opaque hard prolonged-release capsules marked VEN on one side and 75 or 150 on the other. Presentation: 75mg-28, €22.79; 150mg-28, €38.48. Indications: Major depressive episodes. Pharmacology: Venlafaxine is a structurally novel antidepressant which [...]
Prescription. GMS. Sport permitted LEO Pharma is pleased to announce the launch of a new treatment for scalp psoriasis, Xamiol gel (calcipotriol 50 mcg/g and betamethasone dipropionate 0.5mg/g). LEO Pharma has conducted extensive clinical trials with Xamiol showing that Xamiol is significantly more effective than either of the active ingredients used alone for scalp psoriasis. [...]
Prescription. GMS. Sport permitted. Yaz is the first everyday pill on the Irish market containing the unique progestin drospirenone combined with a low dose of ethinyl estradiol taken every day for 28 days – 24 days of active hormone tablets followed by 4 days of hormone free tablets. All other oral contraceptive pills currently available [...]
The new World Anti-Doping Code and accompanying 2009 Prohibited List comes into effect on 1 January 2009. Changes to the List are as a result of stakeholder comments and ongoing reviews by the World Anti-Doping Agency (WADA). Asthmatic patients in particular will be affected by the changes, which are synopsised as follows: • In compliance [...]
Loading ...
